Edgewise Therapeutics, Inc. (EWTX)
30.37
-0.29
(-0.95%)
USD |
NASDAQ |
Feb 12, 16:00
30.35
-0.02
(-0.07%)
After-Hours: 20:00
Edgewise Therapeutics Free Cash Flow : -132.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Dynavax Technologies Corp. | 80.54M |
| Omeros Corp. | -105.32M |
| Gilead Sciences, Inc. | 10.02B |
| Agios Pharmaceuticals, Inc. | -414.09M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -34.78M |
| Cash from Investing (Quarterly) | 35.72M |
| Cash from Financing (Quarterly) | 1.659M |
| Free Cash Flow Per Share (Quarterly) | -0.3305 |
| Free Cash Flow to Equity (Quarterly) | -34.68M |
| Free Cash Flow to Firm (Quarterly) | -34.86M |
| Free Cash Flow Yield | -4.36% |